Germany · Delayed Price · Currency is EUR innoscripta SE Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 43% year-over-year in H1 2026 to EUR 63 million, with EBIT up 49% to EUR 36.4 million. System migration temporarily impacted Q2, but guidance for EUR 140 million revenue and EUR 80 million EBIT is confirmed. International expansion and improved cash collection support long-term growth.
Fiscal Year 2025
-
Revenue and EBIT surged nearly 60% year-over-year, driven by enterprise client wins and product innovation. Management expects continued high growth and margins, supported by regulatory tailwinds and international expansion, with a focus on shareholder returns.
-
Half-year revenue surged 90% year-over-year to EUR 44.1 million, with EBIT more than doubling and margins reaching 58%. Strong customer growth, low churn, and regulatory changes are expected to further boost revenue, while cash flow and profitability remain robust.